scholarly journals Response of Patients with Chest Tightness Variant Asthma with routine asthma management regimen: A one-year Multicenter, Prospective Real-life Study

2020 ◽  
Author(s):  
Fugui Yan ◽  
Wen Li ◽  
Wei Jie Guan ◽  
Min Chen ◽  
Chen Qiu ◽  
...  
Keyword(s):  
Asthma Management ◽  
Real Life ◽  
Chest Tightness ◽  
Life Study ◽  
Real Life Study ◽  
One Year

scholarly journals Economic burden of chronic urticaria in Brazil: A one-year real life study

2020 ◽  
Vol 13 (8) ◽  
pp. 100389
Author(s):  
Priscilla Santos ◽  
Gabriela Dias ◽  
Saint Clair Gomes Junior ◽  
Vivian Ruiz ◽  
Fabio Kuschnir ◽  
...  
Keyword(s):  
Chronic Urticaria ◽  
Economic Burden ◽  
Real Life ◽  
Life Study ◽  
Real Life Study ◽  
One Year

scholarly journals Economic costs of asthma in Brazil: a one year real life study in outpatient setting

2015 ◽  
Vol 8 ◽  
pp. A4 ◽  
Author(s):  
Eduardo Costafsilva ◽  
Rogerio Rufino ◽  
Mauricio Bregman ◽  
Denizar Vianna Araújo ◽  
Claudia Costa
Keyword(s):  
Real Life ◽  
Outpatient Setting ◽  
Economic Costs ◽  
Life Study ◽  
Real Life Study ◽  
One Year

scholarly journals Clinical Data on Transitory Teriparatide-related Hypercalcemia in Daily Practice Treatment for Severe Menopausal Osteoporosis

2019 ◽  
Vol 70 (9) ◽  
pp. 3176-3179
Author(s):  
Edwin Sever Bechir ◽  
Mihaela Jana Tuculina ◽  
Mara Carsote ◽  
Marilena Bataiosu ◽  
Mihaela Raescu ◽  
...  
Keyword(s):  
Real Life ◽  
Daily Practice ◽  
Severe Osteoporosis ◽  
Life Study ◽  
Normal Limits ◽  
Recombinant Molecule ◽  
Real Life Study ◽  
One Year ◽  
Biochemical Features ◽  
Menopausal Osteoporosis

Teriparatide (TPT) (C181H291N55O51S2) represents a recombinant molecule acting as human osteoanabolic agent. Transitory hypercalcemia (TH) has been reported in osteoporotic patients treated with daily TPT. Our purpose is to analyze the biochemical features as well as clinical risk factors for fractures in patients with severe osteoporosis treated with TPT who developed TH during first 12 months. This is an observational real-life study. In patients with TH biochemical blood markers like osteocalcin, CrossLaps and P1NP assessed at one year have statistically significant higher values than in subjects associating serum calcium within normal limits under the drug.

Economic Burden of chronic urticaria in Bazil: a one year real life study

2020 ◽  
Vol 4 (4) ◽  
Author(s):  
Priscilla Filippo Alvim de M. Santos ◽  
Fabio Chigres Kuschnir ◽  
Gabriela Andrade Coelho Dias ◽  
Vivian Pena Ruiz ◽  
Saint Clair Gomes Junior ◽  
...  
Keyword(s):  
Chronic Urticaria ◽  
Economic Burden ◽  
Real Life ◽  
Life Study ◽  
Real Life Study ◽  
One Year

Renal safety after one year of sofosbuvir‐based therapy for chronic hepatitis C: A Brazilian “real‐life” study

2018 ◽  
Vol 43 (5) ◽  
pp. 707-713 ◽  
Author(s):  
T. Medeiros ◽  
N. F. Rosário ◽  
G. N. Saraiva ◽  
T. G. Andrade ◽  
A. A. Silva ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Real Life ◽  
Life Study ◽  
Real Life Study ◽  
One Year ◽  
Renal Safety

Baseline data of the DEVIDE-study: DEnosumab vs Intravenous Ibandronate: a 2-year retrospective head to head real life study

2014 ◽  
Author(s):  
Karin Amrein ◽  
Christian Muschitz ◽  
Doris Wagner ◽  
Thomas R Pieber ◽  
Heinrich Resch ◽  
...  
Keyword(s):  
Real Life ◽  
Baseline Data ◽  
Life Study ◽  
Real Life Study

Pegvisomant: daily versus non daily administration a single centre real life study

2019 ◽  
Author(s):  
Francesca Dassie ◽  
Marco Rosson ◽  
Matteo Parolin ◽  
Lucia Russo ◽  
Sara Mazzocut ◽  
...  
Keyword(s):  
Real Life ◽  
Daily Administration ◽  
Single Centre ◽  
Life Study ◽  
Real Life Study
Sign in / Sign up

Export Citation Format

Share Document